Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2002 3
2004 5
2005 1
2006 5
2007 5
2008 2
2009 4
2011 5
2012 3
2013 3
2014 4
2015 10
2016 7
2017 11
2018 6
2019 4
2020 4
2021 3
2023 3
2024 1
2025 2

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

74 results

Results by year

Filters applied: . Clear all
Page 1
Phase 3 Trial of Concizumab in Hemophilia with Inhibitors.
Matsushita T, Shapiro A, Abraham A, Angchaisuksiri P, Castaman G, Cepo K, d'Oiron R, Frei-Jones M, Goh AS, Haaning J, Hald Jacobsen S, Mahlangu J, Mathias M, Nogami K, Skovgaard Rasmussen J, Stasyshyn O, Tran H, Vilchevska K, Villarreal Martinez L, Windyga J, You CW, Zozulya N, Zulfikar B, Jiménez-Yuste V; explorer7 Investigators. Matsushita T, et al. N Engl J Med. 2023 Aug 31;389(9):783-794. doi: 10.1056/NEJMoa2216455. N Engl J Med. 2023. PMID: 37646676 Free article. Clinical Trial.
Emicizumab in Hemophilia A.
Kruse-Jarres R, Hay CRM. Kruse-Jarres R, et al. Among authors: hay crm. N Engl J Med. 2020 Feb 20;382(8):785. doi: 10.1056/NEJMc1916299. N Engl J Med. 2020. PMID: 32074440 No abstract available.
The epidemiology of factor VIII inhibitors.
Hay CR. Hay CR. Haemophilia. 2006 Dec;12 Suppl 6:23-8; discussion 28-9. doi: 10.1111/j.1365-2516.2006.01362.x. Haemophilia. 2006. PMID: 17123390 Review.
The use of fondaparinux in pregnancy.
Elsaigh E, Thachil J, Nash MJ, Tower C, Hay CR, Bullough S, Byrd L. Elsaigh E, et al. Br J Haematol. 2015 Mar;168(5):762-4. doi: 10.1111/bjh.13147. Epub 2014 Oct 1. Br J Haematol. 2015. PMID: 25270038 No abstract available.
How I treat inhibitors in haemophilia.
Makris M, Hay CR, Gringeri A, D'Oiron R. Makris M, et al. Haemophilia. 2012 Jul;18 Suppl 4:48-53. doi: 10.1111/j.1365-2516.2012.02829.x. Haemophilia. 2012. PMID: 22726083
Prophylaxis in adults with haemophilia.
Hay CR. Hay CR. Haemophilia. 2007 Sep;13 Suppl 2:10-5. doi: 10.1111/j.1365-2516.2007.01500.x. Haemophilia. 2007. PMID: 17685918 Review.
Recombinant factor VIII products and inhibitor development in previously untreated patients with severe haemophilia A: Combined analysis of three studies.
Volkers P, Hanschmann KM, Calvez T, Chambost H, Collins PW, Demiguel V, Hart DP, Hay CRM, Goudemand J, Ljung R, Palmer BP, Santagostino E, van Hardeveld EM, van den Berg M, Keller-Stanislawski B. Volkers P, et al. Among authors: hay crm. Haemophilia. 2019 May;25(3):398-407. doi: 10.1111/hae.13747. Epub 2019 May 7. Haemophilia. 2019. PMID: 31066174 Review.
Inhibitors in nonsevere haemophilia A: outcome and eradication strategies.
van Velzen AS, Eckhardt CL, Hart DP, Peters M, Rangarajan S, Mancuso ME, Smiers FJ, Khair K, Petrini P, Jiménez-Yuste V, Hay CR, van der Bom JG, Yee TT, Fijnvandraat K; INSIGHT study group. van Velzen AS, et al. Thromb Haemost. 2015 Jul;114(1):46-55. doi: 10.1160/TH14-11-0940. Epub 2015 Apr 16. Thromb Haemost. 2015. PMID: 25879247
74 results